Skip to main content

Want a detailed portfolio tracker?

Performance analysis of AgeX Therapeutics (SER)

Annual Return

Over the past 3 years, SER has had an average annual return of -56.95%, underperforming the benchmark SPY, which returned +19.63% annual.

Over the past 5 years, SER has had an average annual return of -47.95%, underperforming the benchmark SPY, which returned +12.73% annual.

Since Nov 29, 2018, SER has had an average annual return of -39.44%, underperforming the benchmark SPY, which returned +15.81% annual.

202620252024202320222021202020192018
+9.09%-61.78%-63.55%-30.24%-49.35%-28.29%-16.48%-39.13%+10.33%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+69.70%-44.64%+7.53%-6.00%+1.06%+5.26%+8%+9.09%
2025-6.18%+5.97%+13.79%+11.26%-4.91%+2.58%-10.06%-3.85%+0.73%-6.68%-14.89%-55.00%-61.78%
2024+6.47%-7.07%-1.07%-33.86%+5.65%+1.85%-4.85%-12.42%-16.24%+2.03%-23.12%-4.43%-63.55%
2023+35.89%-21.35%+12.36%-12.51%-13.79%+78.64%-18.26%+4.08%-10.52%-11.76%-38.84%+4.95%-30.24%
2022-26.36%-14.65%+24.64%+0.76%-15.78%-20.49%+22.91%-19.52%-1.47%+6.85%-6.68%-1.40%-49.35%
2021+14.48%+15.51%-19.40%-14.82%-7.97%+22.07%-12.90%-23.71%-8.73%-13.84%-13.58%+55.71%-28.29%
2020-24.73%-16.04%-19.13%-9.27%+33.91%-16.21%+11.93%-16.67%-8.28%+96.29%+11.32%-14.12%-16.48%
2019+29.43%+9.82%-4.71%+12.59%-38.38%+30.60%-20.16%-7.17%-27.95%-20.41%-8.96%+28.17%-39.13%
2018+99.26%-44.63%+10.33%

Drawdown analysis of AgeX Therapeutics (SER)

The maximum drawdown for the SER was -99.35%, occurring on Mar 18, 2026. This drawdown has not yet recovered.

The current SER drawdown is -98.94%.

Since Nov 29, 2018 SER has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-99.35%Dec 3, 20181830Mar 18, 2026OngoingOngoingOngoing